Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Reprod Domest Anim ; 59(5): e14596, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38757656

RÉSUMÉ

Chlorogenic acid (CGA) is an effective phenolic antioxidant that can scavenge hydroxyl radicals and superoxide anions. Herein, the protective effects and mechanisms leading to CGA-induced porcine parthenogenetic activation (PA) in early-stage embryos were investigated. Our results showed that 50 µM CGA treatment during the in vitro culture (IVC) period significantly increased the cleavage and blastocyst formation rates and improved the blastocyst quality of porcine early-stage embryos derived from PAs. Then, genes related to zygotic genome activation (ZGA) were identified and investigated, revealing that CGA can promote ZGA in porcine PA early-stage embryos. Further analysis revealed that CGA treatment during the IVC period decreased the abundance of reactive oxygen species (ROS), increased the abundance of glutathione and enhanced the activity of catalase and superoxide dismutase in porcine PA early-stage embryos. Mitochondrial function analysis revealed that CGA increased mitochondrial membrane potential and ATP levels and upregulated the mitochondrial homeostasis-related gene NRF-1 in porcine PA early-stage embryos. In summary, our results suggest that CGA treatment during the IVC period helps porcine PA early-stage embryos by regulating oxidative stress and improving mitochondrial function.


Sujet(s)
Acide chlorogénique , Techniques de culture d'embryons , Développement embryonnaire , Mitochondries , Stress oxydatif , Parthénogenèse , Espèces réactives de l'oxygène , Animaux , Stress oxydatif/effets des médicaments et des substances chimiques , Parthénogenèse/effets des médicaments et des substances chimiques , Mitochondries/effets des médicaments et des substances chimiques , Techniques de culture d'embryons/médecine vétérinaire , Acide chlorogénique/pharmacologie , Développement embryonnaire/effets des médicaments et des substances chimiques , Espèces réactives de l'oxygène/métabolisme , Blastocyste/effets des médicaments et des substances chimiques , Suidae , Potentiel de membrane mitochondriale/effets des médicaments et des substances chimiques , Antioxydants/pharmacologie , Femelle , Glutathion/métabolisme
2.
Animals (Basel) ; 13(6)2023 Mar 13.
Article de Anglais | MEDLINE | ID: mdl-36978582

RÉSUMÉ

As a pentacyclic triterpene, MA exhibits effective free radical scavenging capabilities. The purpose of this study was to explore the effects of MA on porcine early-stage embryonic development, oxidation resistance and mitochondrial function. Our results showed that 1 µM was the optimal concentration of MA, which resulted in dramatically increased blastocyst formation rates and improvement of blastocyst quality of in vitro-derived embryos from parthenogenetic activation (PA) and somatic cell nuclear transfer (SCNT). Further analysis indicated that MA supplementation not only significantly decreased the abundance of intracellular reactive oxygen species (ROS) and dramatically increased the abundance of intracellular reductive glutathione (GSH) in porcine early-stage embryos, but also clearly attenuated mitochondrial dysfunction and inhibited apoptosis. Moreover, Western blotting showed that MA supplementation upregulated OCT4 (p < 0.01), SOD1 (p < 0.0001) and CAT (p < 0.05) protein expression in porcine early-stage embryos. Collectively, our data reveal that MA supplementation exerts helpful effects on porcine early embryo development competence via regulation of oxidative stress (OS) and amelioration of mitochondrial function and that MA may be useful for increasing the in vitro production (IVP) efficiency of porcine early-stage embryos.

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE